{
    "clinical_study": {
        "@rank": "42025", 
        "acronym": "NO-Stress", 
        "arm_group": [
            {
                "arm_group_label": "Antioxidant Cocktail", 
                "arm_group_type": "Experimental", 
                "description": "Following an overnight fast, blood samples, flow-mediated dilation, and nitroglycerin mediated dilation (NMD; 0.4mg sub-lingual nitroglycerin spray) will be performed at baseline and 2 hours following either a single dose oral antioxidant cocktail (1000 mg Vitamin C, 600 IU vitamin E, 600 mg Alpha Lipoic Acid) or placebo on two days separated by at least 72 hours."
            }, 
            {
                "arm_group_label": "Biopsy", 
                "arm_group_type": "Other", 
                "description": "Following an overnight fast, a subcutaneous gluteal/hip fat biopsy sample will be obtained from each subject under local anesthesia, with adipose tissue (~2x1.5x1.5cm) to be harvested and placed immediately in physiological saline solution (PSS): Small arteries, 100 to 150 um in diameter, will be dissected from the fat under a dissecting microscope, transferred to an arteriographic bath chamber, and cannulated for pressurized myography."
            }
        ], 
        "brief_summary": {
            "textblock": "Cardiovascular disease is the leading cause of death in the United States. Other studies\n      have shown that stress, early in life, could be a risk factor for cardiovascular disease,\n      later in life. This study will look at the effect of early life stressors on your\n      cardiovascular health."
        }, 
        "brief_title": "Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)", 
        "completion_date": {
            "#text": "April 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Cardiovascular Disease", 
        "condition_browse": {
            "mesh_term": [
                "Cardiovascular Diseases", 
                "Stress, Psychological"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will have two parts involved to investigate the role that childhood SES status\n      has on cardiovascular health.\n\n      Part one: Subjects will give a blood sample which will be processed and analyzed. Flow\n      mediated dilation (FMD) and Pulse wave velocity (PWV/PWA) will be performed at baseline and\n      2 hours following either a single dose oral antioxidant cocktail (1000 mg of Vitamin C, 600\n      IU of Vitamin E, and 600 mg of alpha-lipoic acid) or placebo on two days separated by at\n      least 72 hours. Nitroglycerin mediated dilation (NMD, 0.4mg sub-lingual nitroglycerin\n      spray), will be assessed at baseline.\n\n      Part two: Subjects, if interested will undergo a subcutaneous gluteal/hip fat biopsy. Micro\n      vessels will be isolated from the adipose tissue and analyzed by pressurized myography for\n      endothelial function and nitric oxide bioavailability."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  documented childhood SES\n\n          -  men and premenopausal women ages 18-40\n\n          -  lean/overweight/or obese with BMI< or equal to 39kg/m2\n\n        Exclusion Criteria:\n\n          -  cardiovascular, renal, pulmonary, hepatic, cerebral, or metabolic,disease\n\n          -  use medications that affect vascular tone\n\n          -  post menopausal women\n\n          -  have class 3 obesity or BMI over 40"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "340", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02115724", 
            "org_study_id": "NO-Stress Pro00001887", 
            "secondary_id": "5P01HL069999"
        }, 
        "intervention": [
            {
                "arm_group_label": "Antioxidant Cocktail", 
                "description": "Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment", 
                "intervention_name": "Antioxidant cocktail", 
                "intervention_type": "Dietary Supplement", 
                "other_name": [
                    "Vitamin C", 
                    "Vitamin E", 
                    "Alpha Lipoic Acid"
                ]
            }, 
            {
                "arm_group_label": "Biopsy", 
                "intervention_name": "Biopsy", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Antioxidant Cocktail", 
                "description": "Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Antioxidant Cocktail", 
                "description": "Nitroglycerin mediated dilation will be measured immediately following an administered 0.4mg dose of nitroglycerin spray, sub-lingual.", 
                "intervention_name": "NMD; 0.4mg sub-lingual nitroglycerin spray", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Generic name: Nitrolingual", 
                    "Manufacturer: Arbor Pharmaceuticals"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antioxidants", 
                "Ascorbic Acid", 
                "Thioctic Acid", 
                "Nitric Oxide", 
                "Vitamin E", 
                "Vitamins", 
                "Nitroglycerin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Low childhood SES", 
            "Early Life Stress", 
            "Endothelial function", 
            "Flow mediated dilation", 
            "Cardiovascular disease", 
            "Subcutaneous adipose arterioles"
        ], 
        "lastchanged_date": "April 15, 2014", 
        "location": {
            "contact": {
                "email": "ryharris@gru.edu", 
                "last_name": "Ryan Harris, PhD", 
                "phone": "706-721-5998"
            }, 
            "contact_backup": {
                "email": "jmusall@gru.edu", 
                "last_name": "Jacqueline Musall, BS", 
                "phone": "706 721-8515"
            }, 
            "facility": {
                "address": {
                    "city": "Augusta", 
                    "country": "United States", 
                    "state": "Georgia", 
                    "zip": "30912"
                }, 
                "name": "Georgia Prevention Center , Georgia Regents University"
            }, 
            "investigator": {
                "last_name": "Ryan Harris, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Low Childhood Socioeconomic Status (SES) on Adult Endothelial Function and Nitric Oxide Bioavailability in Vivo and ex Vivo", 
        "overall_contact": {
            "email": "ryharris@gru.edu", 
            "last_name": "Ryan Harris, PhD", 
            "phone": "706 721-5998"
        }, 
        "overall_contact_backup": {
            "email": "jmusall@gru.edu", 
            "last_name": "Jacqueline Musall, BS", 
            "phone": "706 721-5998"
        }, 
        "overall_official": {
            "affiliation": "Georgia Regents University", 
            "last_name": "Ryan Harris, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Data and Safety Monitoring Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment", 
                "measure": "Acute Change in Flow mediated dilation", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline (2 hours)"
            }, 
            {
                "description": "Flow-Mediated Dilation will be determined at baseline and 2 hours following placebo treatment", 
                "measure": "Acute Change in Flow mediated dilation", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline (2 hours)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02115724"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Georgia Regents University", 
            "investigator_full_name": "Ryan Harris", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Nitrite/nitrate, antioxidant capacity, and 8-isoprostane at baseline and 2 hours following acute antioxidant treatment", 
                "measure": "Acute Change in Biomarkers of oxidative stress", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline (2 hours)"
            }, 
            {
                "description": "Pulse wave velocity will be determined at baseline and 2 hours following acute antioxidant treatment", 
                "measure": "Acute Change in Arterial Stiffness", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline (2 hours)"
            }, 
            {
                "description": "Nitroglycerin mediated dilation will be measured immediately following an administered 0.4mg dose of nitroglycerin spray, sub-lingual.", 
                "measure": "Acute change in Flow mediated dilation", 
                "safety_issue": "No", 
                "time_frame": "Immediate"
            }
        ], 
        "source": "Georgia Regents University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Georgia Regents University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}